StocktoriaINTELLIGENT BIO SOLUTIONS INC. INBS
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
3/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $3.1M | $3.1M | $1.3M | $437,146 | $2.0M |
| Gross profit | $1.2M | $1.4M | $326,668 | — | — |
| Operating income | -$10.6M | -$10.3M | -$12.6M | -$8.3M | -$5.6M |
| Net income | -$10.6M | -$10.2M | -$10.6M | -$8.3M | -$7.0M |
| Operating cash flow | -$9.7M | -$9.6M | -$7.4M | -$3.4M | -$11.3M |
| Free cash flow | -$9.9M | -$9.8M | — | — | — |
| Total assets | $8.2M | $13.8M | $10.4M | $12.4M | $21.9M |
| Total liabilities | $5.4M | $5.6M | $6.7M | $5.8M | $6.9M |
| Shareholders' equity | $3.0M | $8.2M | $3.7M | $6.5M | $15.0M |
| Ratios | |||||
| Gross margin | 40.8% | 45.8% | 26.0% | — | — |
| Operating margin | -348.7% | -330.5% | -1002.1% | -1907.1% | -281.4% |
| Net margin | -346.2% | -326.4% | -845.9% | -1900.1% | -355.3% |
| FCF margin | -324.6% | -314.7% | — | — | — |
| Return on assets | -128.1% | -73.7% | -102.7% | -67.2% | -32.2% |
| Return on equity | -352.7% | -124.1% | -288.4% | -126.9% | -46.9% |
| Current ratio | 0.77 | 1.57 | 0.66 | 2.33 | 4.94 |
| Revenue growth | -1.9% | 147.6% | 187.5% | -77.9% | 949.3% |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001725430 · as of 2025-06-30. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.